Aleor gets USFDA nod for Testosterone Topical Solution

Testosterone is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone

31
USFDA
Picture: Pixabay

Last Updated on June 18, 2021 by The Health Master

Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Testosterone Topical Solution USP, 30 mg per pump actuation.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Axiron Topical Solution, 30 mg per pump actuation, of Eli Lilly and Company (Lilly).

Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) and Hypogonadotropic hypoqonadisrn (congenital or acquired).

Testosterone Topical Solution USP, 30 mg per pump actuation has an estimated market size of US$ 21 million for twelve months ending March 2021 according to IQVIA.

Alembic has a cumulative total of 145 ANDA approvals (127 final approvals and 18 tentative approvals) from USFDA.

Avenue Therapeutics gets complete response letter from USFDA for IV Tramadol

Natco gets USFDA nod for Carfilzomib Injection

Lupin gets warning letter from USFDA for Somerset facility

Lupin gets USFDA nod for generic drug to treat HIV infection

Glenmark gets USFDA nod for Theophylline ER tablets

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Schedules: All types of Drugs

Schedules: All types of Cosmetics

Schedules: All types of Medical Devices

cGMP workshop: Making India’s Pharma Industry future ready

Bar Coding for Pharma Products: Govt defers proposal

Govt allows export of Remdesivir injection and its API

Subscribe for daily free updates

Telegram
WhatsApp
Facebook
LinkedIn

Enter your email address:

Delivered by FeedBurner